The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study by Shuhan Xie, Shuhan Xie, Shuhan Xie, Shuhan Xie, Shijie Huang, Zilu Tang, Hai Zhang, Jinxin Xu, Sunkui Ke, Jinbiao Xie, Rongyu Xu, Ying Chen, Zhinuan Hong, Zhinuan Hong, Zhinuan Hong, Zhinuan Hong, Mingqiang Kang, Mingqiang Kang, Mingqiang Kang, Mingqiang Kang

Get full text

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma by Peipei Zhang, Weiguang Zhang, Zhinuan Hong, Junfei Jiang, Ningzi Wu, Jihong Lin, Mingqiang Kang

Get full text

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis by Hui Xu, Zhinuan Hong, Ye Lin, Sunkui Ke, Zhen Chen, Shuhan Xie, Dinghang Chen, Kaiming Peng, Peipei Zhang, Mingduan Chen, Ziyang Han, Jihong Lin, Shuchen Chen, Jinxin Xu, Jinbiao Xie, Mingqiang Kang

Get full text